Two phases of the contingent negative variation in humans: Association with motor and mental functions

Neuroscience and Behavioral Physiology

Volumn 36, Issue 4, 2006, Pages 359-365

  Lukhanina, E P ^a   Karaban', I N ^b   Burenok, Yu A ^b   Mel'nik, N A ^b   Berezetskaya, N M ^b  

^a BOGOMOLETZ INSTITUTE OF PHYSIOLOGY   (Ukraine)

^b INSTITUTE OF GERONTOLOGY   (Ukraine)

Author keywords

Contingent negative variation; Levodopa; Mental functions; Motor functions; Parkinson's disease

Indexed keywords

CARBIDOPA PLUS LEVODOPA;

ADULT; AGED; ARTICLE; BASAL GANGLION; CEREBELLUM; CONTINGENT NEGATIVE VARIATION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; MENTAL DISEASE; MENTAL FUNCTION; MOTOR CONTROL; MOTOR COORDINATION; MOTOR CORTEX; MOTOR PERFORMANCE; PARKINSON DISEASE; PREFRONTAL CORTEX; THALAMUS;

ACOUSTIC STIMULATION; AGED; ANTIPARKINSON AGENTS; CONTINGENT NEGATIVE VARIATION; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; FEMALE; HUMANS; LEVODOPA; MALE; MENTAL PROCESSES; MIDDLE AGED; MUSCLE, SKELETAL; PARKINSON DISEASE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMOTOR PERFORMANCE; TIME FACTORS;

EID: 33645469984     PISSN: 00970549     EISSN: 1573899X     Source Type: Journal    
DOI: 10.1007/s11055-006-0025-9     Document Type: Article

References (27)

1. N. A. Arkhipova, E. M. Troshina, and V. A. Shabalov, "Generation of movement-associated brain potentials in humans in various types of motor pathology," Zh. Vyssh. Nerv. Deyat., 41, No. 4, 655-662 (1991).
2. M. I. Vendrova, R. A. Saderkov, and V. L. Golubev, "The efficiency of new forms of Madopar in Parkinson's disease," Zh. Nevropatol. Psikhiatrii, 100, No. 12, 46-49 (2000).
3. V. V. Gnezditskii, Evoked Brain Potentials in Clinical Practice [in Russian], MEDpress-inform, Moscow (2003).
4. L. R. Zenkov and M. A. Ronkin, Functional Diagnosis of Nervous Diseases [in Russian], MEDpress-inform, Moscow (2004).
5. I. N. Krylov, "Characteristics of endogenous evoked potentials in psychomotor responses in normal conditions and in dysfunction of the basal ganglia in humans," Ros. Fiziol. Zh. im. I. M. Sechenova, 81, No. 4, 51-62 (1995).
6. G. F. Lakin, Biometrics [in Russian], Vysshaya Shkola, (1973).
7. E. M. Troshina, "Characteristics of motor potentials in impairments of the function of the subcortical motor structures of the human brain," Zh. Vyssh. Nerv. Deyat., 39, No. 1, 37-43 (1989).
8. G. Amabile, F. Fattapposta, G. Pozzessere, G. Albani, L. Sanarelli, P. A. Rizzo, and C. Morocutti, "Parkinson's disease: electrophysiological (CNV) analysis related to pharmacological treatment," EEG Clin. Neurophysiol., 64, No. 6, 521-524 (1986).
9. A. Aotsuka, S. J. Wheate, M. E. Dranke, Jr., and G. W. Paulson, "Event-related potentials in Parkinson's disease," Electromyogr. Clin. Neurophysiol., 36, No. 4, 215-220 (1996).
10. A. L. Bartels, Y. Balash, T. Gurevich, J. D. Schaafsma, J. M. Hausdorff, and N. Giladi, "Relationship between freezing of gait (FOG) and other features of Parkinson's FOG is not correlated with bradykinesia," J. Clin. Neurosci., 10, No. 5, 584-588 (2003).
11. K. Botzel, M. Mayer, W. H. Oertel, and W. Paulus, "Frontal and parietal premovement slow brain potentials in Parkinson's disease and aging," Mov. Disord., 10, No. 1, 85-91 (1995).
12. L. Deecke, "Clinical neurophysiology of Parkinson's disease. Bereitschaftpotential and contingent negative variation," Adv. Neurol., 86, 257-271 (2001).
13. S. R. Filipovic, N. Covickovic-Sternic, V. M. Radovic, N. Dragasevic, M. Stoyanovic-Svete, and V. S. Kostic, "Correlation between Bereitschaftspotential and reaction time measurements in patients with Parkinson's disease. Measuring the impaired supplementary motor area function?" J. Neurol. Sci., 147, No. 2, 177-183 (1997).
14. W. Gerschlager, F. Alesch, R. Cunnington, L. Deecke, G. Dirnberger, W. Endl, G. Lindinger, and W. Lang, "Bilateral subthalamic nucleus stimulation improves frontal cortex function in Parkinson's disease. An electrophysiological study of the contingent negative variation," Brain, 122, No. 12, 2365-2373 (1999).
15. A. Ikeda, H. Shibasaki, R. Kaji, K. Terada, T. Nagamine, M. Honda, and J. Kimura, "Dissociation between contingent negative variation (CNV) and Bereitschaftspotential (BP) in patients with parkinsonism," EEG Clin. Neurophysiol., 102, No. 2, 142-151 (1997).
16. Y. Katayama, M. Kasai, H. Oshima, C. Kufaya, and T. Yamamoto, "Effects of anterodorsal pallidal stimulation on gait freezing (Kinesia paradoxa) in Parkinson's disease," Stereotact. Funct. Neurosurg., 74, No. 3-4, 99-105 (2000).
17. G. Kemoun and L. Defebvre, "Gait disorders in Parkinson disease. Gait freezing and falls: Therapeutic management," Presse Med., 30, No. 9, 460-468 (2001).
18. M. Oishi, Y. Mochizuki, C. Du, and T. Takasu, "Contingent negative variation and movement-related cortical potentials in parkinsonism," EEG Clin. Neurophysiol., 95, No. 5, 346-349 (1995).
19. A. Parent and L. N. Hazrati, "Anatomical aspects of information processing in primate basal ganglia," Trends Neurosci., 16, No. 3, 111-116 (1993).
20. F. Pulvermuller, W. Lutzenberger, V. Muller, B. Mohr, J. Dichgans, and N. Birbaumer, "P3 and contingent negative variation in Parkinson's disease," EEG Clin. Neurophysiol., 98, No. 6, 456-467 (1996).
21. K. Saitou and Y. Washimi, "Movement related conical potentials upon forward-stepping in patients with Parkinson's disease," Nippon Rinsho, 55, No. 1, 185-188 (1997).
22. J. D. Schaarsma, Y. Balash, T. Gurevich, A. L. Bartels, J. M. Hausdorff, and N. Giladi, "Characterization of freezing of gait subtypes and the response of each to levodopa in Parkinson's disease," Eur. J. Neurol., 10, No. 4, 391-398 (2003).
23. H. Shibasaki, G. Barrett, E. Halliday, and A. M. Halliday, "Components of the movement-related cortical potential and their scalp topography," EEG. Clin. Neurophysiol., 49, No. 3-4, 213-226 (1980).
24. R. Verleger, E. Wascher, V. Arolt, C. Daase, A. Strohm, and D. Kompf, "Slow EEC-potentials (contingent negative variation and post-imperative negative variation) in schizophrenia: Their association to the present state and to Parkinsonian medication effects," Clin. Neurophysiol., 110, No. 7, 1175-1192 (1999).
25. E. Wascher, R. Verleger, P. Vieregge, P. Jaskowski, S. Koch, and D. Koompf, "Responses to cued signals in Parkinson's disease. Distinguishing between disorders of cognition and of activation," Brain, 120, No. 8, 1355-1375 (1997).
26. S. Yazawa, A. Ikeda, R. Kaji, K. Terada, T. Negamine, K. Toma, T. Kubori, J. Kimura, and H. Shibasaki, "Abnormal cortical processing of voluntary muscle relaxation in patients with focal hand dystonia studied by movement-related potentials," Brain, 122, 1357-1366 (1999).
27. R. Zappoli, A. Versari, G. Arnetoli, M. Paganini, G. C. Muscas, M. G. Arneodo, P. F. Gangemi, and M. Bartelli, "Topographic CNV activity mapping, presenile mild primary cognitive decline and Alzheimer-type dementia," Neurophysiol. Clin., 21, No. 5-6, 473-483 (1991).